Table 1.
Patient | Age,y | M:F | Other Medical Conditions | Size at Time of PET (cm 3) | MDT Classification | Tumor Side | Cystic/Solid Tumor | Clinical Outcome | Histology (if known) |
---|---|---|---|---|---|---|---|---|---|
1 | 66.6 | F | HTN, T2DM, ocular melanoma (left eye), CKD stage 3 | 0.26 | Shrinking | R | Solid | Follow-up | NA |
2 | 32.3 | M | Nil | 1.88 | Growing | L | Solid | Surgery | Schwannoma, WHO grade I |
3 | 25.7 | M | Nil | 3.82 | Growing | R | Small posteromedial cyst | Surgery | Schwannoma, WHO grade I |
4 | 58.8 | F | T2DM, HTN | 0.92 | Static | R | Solid | Follow-up | NA |
5 | 60.8 | F | Nil | 1.03 | Static | R | Solid | Follow-up | NA |
6 | 56.3 | F | Depression | 0.30 | Static | R | Solid | Surgery | Schwannoma, WHO grade I |
7 | 69.2 | F | OA, anxiety | 0.59 | Shrinking | L | Solid | Follow-up | NA |
8 | 26.8 | M | Nil | 1.92 | Shrinking | L | Small cysts | Follow-up | NA |
9 | 61.1 | F | Hashimoto’s, OA, hypothyroidism, Raynaud’s, pre-diabetes | 0.37 | Static | R | Solid | Surgery | Schwannoma, WHO grade I |
10 | 76.1 | F | Nil | 1.25 | Static | L | Small anterolateral cyst | Follow-up | NA |
11 | 74.9 | M | T2DM | 1.09 | Growing | R | Solid | SRS | NA |
12 | 64.6 | F | Nil | 0.97 | Growing | R | Solid | SRS | NA |
13 | 73.9 | F | Hypothyroidism | 0.80 | Static | R | Solid | Follow-up | NA |
14 | 80.7 | M | BPH | 0.99 | Shrinking | R | Solid | Follow-up | NA |
15 | 63.0 | M | Asthma | 0.38 | Static | L | Solid | Surgery | Schwannoma, WHO grade I |
16 | 58.2 | M | HTN | 0.73 | Static | R | Solid | Follow-up | NA |
17 | 54.3 | M | HTN | 3.33 | Growing | L | Solid | Surgery | Schwannoma, WHO grade I |
18 | 54.8 | F | T2DM | 5.71 | Growing | L | Small multiple cysts | Surgery | Schwannoma, WHO grade I |
19 | 39.0 | F | Nil | 2.61 | Growing | R | Small multiple cysts | Surgery | Schwannoma, WHO grade I |
BPH = benign prostatic hypertrophy; CKD = chronic kidney disease; HTN = hypertension; NA = not applicable; OA = osteoarthritis; SRS = stereotactic radiosurgery; T2DM = type 2 diabetes.